SPONSOR
Samsung Medical Center
Total Trials
11
Recruiting
11
Phases
Phase 2, Phase 1, Phase 2
Conditions studied: Non-small Cell Lung CancerCoronary Artery DiseaseChronic Coronary SyndromeAcute Coronary SyndromeEarly Gastric CancerGastric AdenomaOne Lung Ventillation (OLV)Premenopausal HR+/HER2- Metastatic Breast CancerB-cell Lymphoma RecurrentB-cell Lymphoma Refractory
Samsung Medical Center is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Non-small Cell Lung Cancer, Coronary Artery Disease, Chronic Coronary Syndrome, Acute Coronary Syndrome.
The trial portfolio spans Phase 2, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Samsung Medical Center
How many clinical trials has Samsung Medical Center sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by Samsung Medical Center, of which 11 are actively recruiting participants. These trials cover conditions including Non-small Cell Lung Cancer, Coronary Artery Disease, Chronic Coronary Syndrome. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Samsung Medical Center research focus on?
Samsung Medical Center clinical trials span Non-small Cell Lung Cancer, Coronary Artery Disease, Chronic Coronary Syndrome, Acute Coronary Syndrome, Early Gastric Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Samsung Medical Center clinical trial?
To participate in a Samsung Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Samsung Medical Center trials with current recruitment status updated daily.
Clinical Trials by Samsung Medical Center
NCT03791034
Recruiting
Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
Non-small Cell Lung Cancer
NCT07329699
Recruiting
Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)
Coronary Artery Disease
NCT04665687
Recruiting
Clinical Application of Genetic Sequencing of Early Gastric Cancer and Gastric Adenoma Patients
Early Gastric Cancer
NCT06897501
Recruiting
Postoperative Vocal Cord Palsy Between Double-lumen Endobronchial Tube and Bronchial Blocker for Robot-assisted Esophagectomy
One Lung Ventillation (OLV)
NCT04819243 Phase 2
Recruiting
PALbociclib Endocrine Therapy Followed by Talazo Vs. Talazoz-Atezo Study
Premenopausal HR+/HER2- Metastatic Breast Cancer
NCT06552559 Phase 1, Phase 2
Recruiting
Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma
B-cell Lymphoma Recurrent
NCT06270238
Recruiting
Efficacy of Personalized Repetitive Transcranial Magnetic Stimulation Protocol Based on Functional Reserve to Enhance Upper Limb Function in Subacute Stroke Patients
Stroke
NCT06479421
Recruiting
A Clinical Study for Developing Artificial Intelligence(AI)-Based Clustering Model for Personalized Medicine in Acute Respiratory Failure
Acute Respiratory Failure
NCT06461819 Phase 2
Recruiting
Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-intermediate Risk Localized Prostate Cancer (DESAR-L)
Low-to-intermediate-risk Prostate Carcinoma
NCT05828719
Recruiting
Revascularization Versus Medical Treatment in Patients With Ischemic Left Ventricular Dysfunction
Heart Failure With Reduced Ejection Fraction
NCT05812963
Recruiting
IVUS Versus FFR for Non-infarct Related Artery Lesions in Patients With Multivessel Disease and Acute MI
ST Elevation Myocardial Infarction
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology